Erector Spinae Plane block in Renal Transplant Recipient

To study the effect of ultrasound guided erector spinae plane block for post operative analgesia in renal transplant recipient: A case control comparative study

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/025545

Enrollment

Registered

2020-06-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N186- End stage renal disease

Interventions

Intervention1: Erector spinae plane block with 0.5% Ropivacaine: Erector spinae plane block using 30 mL of 0.5% Ropivacaine Control Intervention1: Erector spinae plane block with normal saline: Erecto

Eligibility

Inclusion criteria

Inclusion criteria: Patients of end-stage renal disease undergoing renal transplantation aged between 18 and 65 years and weighing between 40 and 70 kg

Exclusion criteria

Exclusion criteria: Refusal to participate Coagulopathy Localised infection at the proposed site of infection Mentally ill Known allergy to local anaesthetics Morbid obesity

Design outcomes

Primary

Measure	Time frame
Post-operative pain at rest and dynamic pain using Visual Analogue Score Fentayl consumptionTimepoint: Post-operative pain at rest and dynamic pain using Visual Analogue Score	—

Secondary

Measure	Time frame
Consumption of opioids and other analgesicsTimepoint: Post operative period	—

Countries

India

Contacts

Public ContactSandeep Sahu

Sanjay Gandhi Post Graduate Institute of Medical Sciences

drsandeepsahu09@gmail.com80004904598

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026